Showing 64,121 - 64,140 results of 104,200 for search '(( a step decrease ) OR ( 5 ((we decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.03s Refine Results
  1. 64121
  2. 64122
  3. 64123
  4. 64124

    Table_3_Altered Gut Microbiota Composition in Subjects Infected With Clonorchis sinensis.XLSX by Meng Xu (62933)

    Published 2018
    “…What’s more, the reduction in the abundance of Bifidobacterium, a common probiotic, was decreased particularly in the 60 + years old group (r = −0.50, P = 0.04). …”
  5. 64125

    Potential Regulatory Role of Human-Carboxylesterase‑1 Glycosylation in Liver Cancer Cell Growth by Keun Na (1666186)

    Published 2020
    “…We previously reported that human carboxylesterase 1 (CES1), a serine esterase containing a unique <i>N</i>-linked glycosyl group at Asn79 (N79 CES1), is a candidate serological marker of hepatocellular carcinoma (HCC). …”
  6. 64126

    Leptin and adiponectin dynamics at patients with rectal neoplasm - Gender differences by Alexandru Florescu (7274390)

    Published 2019
    “…Surgery caused an increase of leptin from 5.11±0.8 to 18.7±2.42 ng/ml, p = 6.85 x 10¨<sup>8</sup>, and a decrease of adiponectin from 9.71±0.58 to 7.87±0.47 μg/ml, p = 1.4 x 10¨<sup>10</sup> for all RC patients and returned thereafter to the initial range at 7 days. …”
  7. 64127

    Inhibition of thrombin activity by administration of direct thrombin inhibitor Dabigatran etexilate or recombinant murine APC substantially attenuates leukocyte recruitment and pre... by Julian I. Borissoff (280594)

    Published 2013
    “…<p>(A) Representative hematoxylin and eosin (H&E)-stained sections of atherosclerotic lesions formed in carotid arteries of TM<sup>Pro/Pro</sup>:ApoE<sup>−/−</sup> mice, which were assigned to different intervention arms (oral Dabigatran etexilate - 7.5 mg DE/gram chow; i.p. administered bolus doses of recombinant murine APC - 2.5 mg/kg/per every 5 days; or placebo) for a total of 6 weeks after cuff placement around the common carotid arteries (top row). …”
  8. 64128

    Knockdown of BMPRII did not affect BMP4 elevated basal [Ca<sup>2+</sup>]<sub>i</sub> and SOCE in PASMCs. by Yi Zhang (9093)

    Published 2014
    “…<p>(A) bar graph showing the changes in basal [Ca<sup>2+</sup>]<sub>i</sub> in distal PASMCs treated with 50 ng/ml BMP4 (n  =  4 from 120 cells) for 60 h. …”
  9. 64129

    Image_2_Astrocytes Downregulate Inflammation in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: Applicability to COVID-19.TIF by Michal Izrael (5343413)

    Published 2021
    “…Next, we tested the therapeutical potential of AstroRx cells in a lipopolysaccharide (LPS)-based ARDS mouse model by injecting AstroRx intravenously (i.v). …”
  10. 64130

    Image_1_Astrocytes Downregulate Inflammation in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: Applicability to COVID-19.TIF by Michal Izrael (5343413)

    Published 2021
    “…Next, we tested the therapeutical potential of AstroRx cells in a lipopolysaccharide (LPS)-based ARDS mouse model by injecting AstroRx intravenously (i.v). …”
  11. 64131

    Image_3_Astrocytes Downregulate Inflammation in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: Applicability to COVID-19.TIF by Michal Izrael (5343413)

    Published 2021
    “…Next, we tested the therapeutical potential of AstroRx cells in a lipopolysaccharide (LPS)-based ARDS mouse model by injecting AstroRx intravenously (i.v). …”
  12. 64132

    Image_4_Astrocytes Downregulate Inflammation in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: Applicability to COVID-19.TIF by Michal Izrael (5343413)

    Published 2021
    “…Next, we tested the therapeutical potential of AstroRx cells in a lipopolysaccharide (LPS)-based ARDS mouse model by injecting AstroRx intravenously (i.v). …”
  13. 64133

    <i>Setd2</i> deficiency altered genome-wide H3K36me3 occupancy and downstream gene expression. by Lijun Wang (176511)

    Published 2018
    “…<p>(A) Oil Red O staining of BMSCs, which were isolated from <i>Setd2</i><sup><i>fl/fl</i></sup> mice and infected with lentivirus expressing GFP and Cre, induced by adipogenesis medium for 6 days. …”
  14. 64134

    Data Sheet 1_Anti-HLA antibodies bound to monocytes altered antibody-mediated platelet phagocytosis and led to mild thrombocytopenia.pdf by Xiuzhang Xu (22363618)

    Published 2025
    “…Furthermore, the administration of anti-MHC-I antibodies to mice led to a significant decrease in the platelet count within 24 h. …”
  15. 64135

    Combined Red Clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms by Max Norman Tandrup Lambert (4093156)

    Published 2017
    “…Effective treatments against VMS with minimal cancer risks are needed. We investigate the effects of a highly bioavailable aglycone rich Red Clover isoflavone treatment to alleviate existing menopausal VMS, assessed for the first time by 24hour ambulatory skin conductance (SC)</p><p>Methods and results</p><p>We conducted a parallel, double blind, randomised control trial of 62 peri-menopausal women aged 40–65, reporting ≥ 5 hot flushes/day and follicle stimulating hormone ≥35 IU/L. …”
  16. 64136

    Image6_Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma.TIF by Yiru Wang (1686439)

    Published 2022
    “…To further investigate the mechanism, we explored the upstream of five lncRNAs and found that they may be modified by m6A to increase or decrease their expression in BC. …”
  17. 64137

    Image4_Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma.TIF by Yiru Wang (1686439)

    Published 2022
    “…To further investigate the mechanism, we explored the upstream of five lncRNAs and found that they may be modified by m6A to increase or decrease their expression in BC. …”
  18. 64138

    Image3_Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma.TIF by Yiru Wang (1686439)

    Published 2022
    “…To further investigate the mechanism, we explored the upstream of five lncRNAs and found that they may be modified by m6A to increase or decrease their expression in BC. …”
  19. 64139

    Image7_Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma.TIF by Yiru Wang (1686439)

    Published 2022
    “…To further investigate the mechanism, we explored the upstream of five lncRNAs and found that they may be modified by m6A to increase or decrease their expression in BC. …”
  20. 64140

    Image8_Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma.TIF by Yiru Wang (1686439)

    Published 2022
    “…To further investigate the mechanism, we explored the upstream of five lncRNAs and found that they may be modified by m6A to increase or decrease their expression in BC. …”